Bleeding Patterns among Adolescents Using the Levonorgestrel Intrauterine Device: A Single Institution Review - 24/09/20
![](/templates/common/images/mail.png)
Abstract |
Study Objective |
To describe the bleeding patterns associated with the use of the levonorgestrel intrauterine device (IUD) in adolescents.
Design, Setting, and Participants |
A retrospective chart review of postmenarchal adolescent patients ages 8-19 years who had the levonorgestrel IUD inserted at Phoenix Children's Hospital from 2012 to 2018.
Interventions |
Insertion of the 52-mg and 13.5-mg levonorgestrel IUD.
Main Outcome Measures |
The rate of amenorrhea and other bleeding patterns after insertion of the levonorgestrel IUD and the factors that might predict those bleeding patterns.
Results |
A total of 260 charts were identified with 221/260 (85.0%) patients choosing the 52-mg IUD and 39/260 (15.0%) patients choosing the 13.5-mg IUD to be inserted. Follow-up data were available for 166 patients. The overall rate of amenorrhea among IUD users was 39.8% (n = 66) with no difference between 52-mg and 13.5-mg IUD users (P = .656). Regularity and flow of menstrual cycle, history of bleeding disorder, history of developmental delay, and current treatment with testosterone for gender dysphoria before IUD insertion did not appear to have a significant effect on the rate of amenorrhea or bleeding patterns post-IUD insertion.
Conclusion |
The levonorgestrel IUD can be successfully used to control abnormal uterine bleeding and suppress menses in adolescents. Menstrual cycle characteristics pre-IUD insertion did not result in predictable post-IUD bleeding patterns.
Le texte complet de cet article est disponible en PDF.Key Words : Abnormal uterine bleeding, Heavy menstrual bleeding, Menstrual suppression, Intrauterine device
Plan
The authors indicate no conflicts of interest. |
|
Presented at the North American Society of Pediatric and Adolescent Gynecology 34th Annual Clinical and Research meeting on April 2-4, 2020 in Grapevine, Texas. |
Vol 33 - N° 5
P. 555-558 - octobre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?